The 10 included studies comprised a mix of randomised controlled trials (RCTs) and observational cohorts evaluating dietary, insulin, and oral therapies for GDM, with sample sizes ranging from fewer than 100 to 1,300 women. The gene discussed is INS; the disease is gestational diabetes.